Literature DB >> 33422000

Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.

Ranashia L Boone1, Briana Whitehead1, Tyra M Avery1, Jacky Lu2, Jamisha D Francis2, Miriam A Guevara2, Rebecca E Moore3, Schuyler A Chambers3, Ryan S Doster4, Shannon D Manning5, Steven D Townsend3, Leon Dent6,7, Dana Marshall6, Jennifer A Gaddy8,9,10, Steven M Damo11,12,13.   

Abstract

BACKGROUND: Acinetobacter baumannii is a gram-negative bacterium which causes opportunistic infections in immunocompromised hosts. Genome plasticity has given rise to a wide range of strain variation with respect to antimicrobial resistance profiles and expression of virulence factors which lead to altered phenotypes associated with pathogenesis. The purpose of this study was to analyze clinical strains of A. baumannii for phenotypic variation that might correlate with virulence phenotypes, antimicrobial resistance patterns, or strain isolation source. We hypothesized that individual strain virulence phenotypes might be associated with anatomical site of isolation or alterations in susceptibility to antimicrobial interventions.
METHODOLOGY: A cohort of 17 clinical isolates of A. baumannii isolated from diverse anatomical sites were evaluated to ascertain phenotypic patterns including biofilm formation, hemolysis, motility, and antimicrobial resistance. Antibiotic susceptibility/resistance to ampicillin-sulbactam, amikacin, ceftriaxone, ceftazidime, cefotaxime, ciprofloxacin, cefepime, gentamicin, levofloxacin, meropenem, piperacillin, trimethoprim-sulfamethoxazole, ticarcillin- K clavulanate, tetracyclin, and tobramycin was determined.
RESULTS: Antibiotic resistance was prevalent in many strains including resistance to ampicillin-sulbactam, amikacin, ceftriaxone, ceftazidime, cefotaxime, ciprofloxacin, cefepime, gentamicin, levofloxacin, meropenem, piperacillin, trimethoprim-sulfamethoxazole, ticarcillin- K clavulanate, tetracyclin, and tobramycin. All strains tested induced hemolysis on agar plate detection assays. Wound-isolated strains of A. baumannii exhibited higher motility than strains isolated from blood, urine or Foley catheter, or sputum/bronchial wash. A. baumannii strains isolated from patient blood samples formed significantly more biofilm than isolates from wounds, sputum or bronchial wash samples. An inverse relationship between motility and biofilm formation was observed in the cohort of 17 clinical isolates of A. baumannii tested in this study. Motility was also inversely correlated with induction of hemolysis. An inverse correlation was observed between hemolysis and resistance to ticarcillin-k clavulanate, meropenem, and piperacillin. An inverse correlation was also observed between motility and resistance to ampicillin-sulbactam, ceftriaxone, ceftoxamine, ceftazidime, ciprofloxacin, or levofloxacin.
CONCLUSIONS: Strain dependent variations in biofilm and motility are associated with anatomical site of isolation. Biofilm and hemolysis production both have an inverse association with motility in the cohort of strains utilized in this study, and motility and hemolysis were inversely correlated with resistance to numerous antibiotics.

Entities:  

Keywords:  Acinetobacter baumannii; Antibiotics; Antimicrobial resistance; Biofilm; Motility

Year:  2021        PMID: 33422000      PMCID: PMC7796680          DOI: 10.1186/s12866-020-02082-1

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  29 in total

Review 1.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  The opportunistic human pathogen Acinetobacter baumannii senses and responds to light.

Authors:  María A Mussi; Jennifer A Gaddy; Matías Cabruja; Brock A Arivett; Alejandro M Viale; Rodolfo Rasia; Luis A Actis
Journal:  J Bacteriol       Date:  2010-10-01       Impact factor: 3.490

3.  Alternative Sigma Factor RpoX Is a Part of the RpoE Regulon and Plays Distinct Roles in Stress Responses, Motility, Biofilm Formation, and Hemolytic Activities in the Marine Pathogen Vibrio alginolyticus.

Authors:  Dan Gu; Jun Zhang; Yuan Hao; Rongjing Xu; Yuanxing Zhang; Yue Ma; Qiyao Wang
Journal:  Appl Environ Microbiol       Date:  2019-07-01       Impact factor: 4.792

4.  Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1.

Authors:  Kai Jiang; Xinlin Yan; Jiahao Yu; Zijian Xiao; Hao Wu; Meihua Zhao; Yuandong Yue; Xiaoping Zhou; Junhai Xiao; Feng Lin
Journal:  Eur J Med Chem       Date:  2020-03-20       Impact factor: 6.514

Review 5.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

6.  Regulation of Acinetobacter baumannii biofilm formation.

Authors:  Jennifer A Gaddy; Luis A Actis
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

7.  The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells.

Authors:  Jennifer A Gaddy; Andrew P Tomaras; Luis A Actis
Journal:  Infect Immun       Date:  2009-05-26       Impact factor: 3.441

Review 8.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

Review 9.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

10.  Proteomics of Campylobacter jejuni Growth in Deoxycholate Reveals Cj0025c as a Cystine Transport Protein Required for Wild-type Human Infection Phenotypes.

Authors:  Lok Man; Ashleigh L Dale; William P Klare; Joel A Cain; Zeynep Sumer-Bayraktar; Paula Niewold; Nestor Solis; Stuart J Cordwell
Journal:  Mol Cell Proteomics       Date:  2020-05-06       Impact factor: 5.911

View more
  4 in total

1.  Identification of Two Variants of Acinetobacter baumannii Strain ATCC 17978 with Distinct Genotypes and Phenotypes.

Authors:  Christiaan D M Wijers; Ly Pham; Swapna Menon; Kelli L Boyd; Hannah R Noel; Eric P Skaar; Jennifer A Gaddy; Lauren D Palmer; Michael J Noto
Journal:  Infect Immun       Date:  2021-08-30       Impact factor: 3.441

2.  Antibiofilm Activity of Human Milk Oligosaccharides against Multidrug Resistant and Susceptible Isolates of Acinetobacter baumannii.

Authors:  Sabrina K Spicer; Rebecca E Moore; Jacky Lu; Miriam A Guevara; Dana R Marshall; Shannon D Manning; Steven M Damo; Steven D Townsend; Jennifer A Gaddy
Journal:  ACS Infect Dis       Date:  2021-11-23       Impact factor: 5.578

3.  Evaluation of a direct phage DNA detection-based Taqman qPCR methodology for quantification of phage and its application in rapid ultrasensitive identification of Acinetobacter baumannii.

Authors:  Jun Luo; Min Liu; Peng Wang; Qianyuan Li; Chunhua Luo; Hongping Wei; Yuanyuan Hu; Junping Yu
Journal:  BMC Infect Dis       Date:  2022-06-07       Impact factor: 3.667

4.  Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates.

Authors:  Tyra M Avery; RaNashia L Boone; Jacky Lu; Sabrina K Spicer; Miriam A Guevara; Rebecca E Moore; Schuyler A Chambers; Shannon D Manning; Leon Dent; Dana Marshall; Steven M Damo; Steven D Townsend; Jennifer A Gaddy
Journal:  ACS Infect Dis       Date:  2021-06-09       Impact factor: 5.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.